Cytochrome P450 2E1: its clinical and toxicological role
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Cytochrome (CYP) P450 2E1 is clinically and toxicologically important and it is constitutively expressed in the liver and many other tissues. In contrast to many other CYP isoenzymes, indisputable evidence for a functionally important polymorphism of CYP2E1 in the human population is lacking. CYP2E1 metabolizes a wide variety of chemicals with different structures, in particular small and hydrophobic compounds, including potential cytotoxic and carcinogenic agents. In addition, chlorzoxazone and trimethadione metabolism are good CYP2E1 probes for liver disease in vivo and in vitro. In the future, methods for fully analysing the function of CYP2E1 using knockout mice will be established. This article reviews recent advances in our understanding of the role of human CYP2E1 in drug metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1×
“The effect of aniline (91) and organosulphur compounds (92), including allylsulphide (AS), allylmercaptan (AM) and allylmethylsulphide (AMS), on the expression of CYP2E1 was examined in rats.”
BackgroundCytochrome P-4502E1: its physiological and pathological role
Lieber, C. S. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.517 · Cited by 889
CORCORAN, G. B., MITCHELL, J. R., VAISHNAV, Y. N., & HORNING, E. C. (1980) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14551-3 · Cited by 247
Song, B. J., & Cederbaum, A. I. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01764.x · Cited by 148
Miners, J. O., Attwood, J., & Birkett, D. J. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.64 · Cited by 90
LIEBER, C. S., LASKER, J. M., ALDERMAN, J., & LEO, M. A. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb48649.x · Cited by 31
CYTOCHROME P450 KNOCKOUT MICE: NEW TOXICOLOGICAL MODELS
McKinnon, R. A., & Nebert, D. W. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02153.x · Cited by 22 · cited 1×
“The CYP null mouse lines (knockout mice) have recently been developed to determine the role of xenobiotic-metabolizing enzymes in mammalian development and physiological homeostasis, and to monitor the sensitivity to chemical toxicity and carcinogenesis (67, 68).”
Background
Cited by
CYP2E1 and oxidative liver injury by alcohol
Lu, Y., & Cederbaum, A. I. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.004 · Cited by 805
Role of oxidative stress in alcohol-induced liver injury
Cederbaum, A. I., Lu, Y., & Wu, D. (2009) · Archives of Toxicology · doi:10.1007/s00204-009-0432-0 · Cited by 596
Alcohol and Oxidative Liver Injury
Dey, A., & Cederbaum, A. I. (2006) · Hepatology · doi:10.1002/hep.20957 · Cited by 557
How Important Are Gender Differences in Pharmacokinetics?
Meibohm, B., Beierle, I., & Derendorf, H. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241050-00002 · Cited by 454
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Hines, R. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.005 · Cited by 410
Metadata
- Authors
- Tanaka, Terada, & Misawa
- Venue
- Journal of Clinical Pharmacy and Therapeutics
- Publisher
- Hindawi Limited
- Published
- 2000-06
- Volume
- 25
- Issue
- 3
- Pages
- 165-175
- ISSN
- 0269-4727 (ISSN-L)
- 1365-2710
- OpenAlex
- W2068396499
- Cited by
- 203
- References
- 8
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.